| Literature DB >> 27981642 |
Hongyan Li1, Jie Song1, Jianghua Zhang2,3, Tianmin Wang1, Yuhui Yan1, Zhenyu Tao1, Shaoheng Li1, Hui Zhang4, Tingguo Kang1, Jingxian Yang1.
Abstract
Ginseng (Panax ginseng C.A. Meyer) is one of the most widely used herbal medicines worldwide. The present study evaluated the neuroprotective effects of ginseng protein (GP) and its possible mechanisms in a cellular and animal model of AD. The results demonstrated that GP (10-100 µg/mL) significantly improved the survival rate of neurons and reduced the cells' apoptosis and the mRNA expression of caspase-3 and Bax/Bcl-2. In addition, GP (0.1 g/kg) significantly shortened the escape latency, prolonged the crossing times and the percentage of residence time; reduced the level of Aβ1-42 and p-tau, the activity of T-NOS and iNOS, and the content of MDA and NO, improved the activity of SOD, the concentration of cAMP and the protein expression of p-PKA/PKA and -CREB/CREB. The results demonstrated that GP significantly inhibited Alzheimer-like pathophysiological changes induced by Aβ25-35 or H2 O2 in cells or those induced by D-gal/ Al in animals. These neuroprotective effects of GP may be associated with the cAMP/PKA/CREB pathway. Also, in combination with our previous studies, these results indicate that the anti-AD mechanism of GP was likely to activate the CREB pathway through multiple channels.Entities:
Keywords: Alzheimer's disease; ginseng; neuroprotective; oxidative stress; protein
Mesh:
Substances:
Year: 2016 PMID: 27981642 DOI: 10.1002/ptr.5747
Source DB: PubMed Journal: Phytother Res ISSN: 0951-418X Impact factor: 5.878